Data Talks with James Pann, Episode 2: Robert Garelick

Data Talks with James Pann, Episode 2: Robert Garelick

Data Talks podcast episode 2 is now ready for your listening pleasure. On Data Talks we explore how people from a wide variety of disciplines use data to make professional and personal decisions.

This episode is with Robert Garelick, Executive Director of the Juvenile Diabetes Research Foundation (JDRF), Rocky Mountain Chapter (http://rockymountain.jdrf.org). JDRF’s goal is to cure type 1 diabetes. Robert has over 23 years experience in sales and with for-profit companies. He made the transition to JDRF about 2 years ago.

We hear from Robert about how his organization uses data to make decisions, the key metrics they monitor regularly, and his process transitioning from the for-profit to the nonprofit world.

 

Show Notes:

Juvenile Diabetes Research Foundation goals

Difference between type 1 and type 2 diabetes

Use of data to make organizational decisions and data systems employed

Large companies and sponsors often get involved because they have some connection to someone impacted by diabetes

How Robert remembers donors’ stories and personal connections to the disease

Communication to funders and the different methods used, including the use of medical professionals to provide information regarding the latest advances

How connections are made with families after an initial diagnosis; introduction to a supportive network

How Robert’s personal experiences impact his role at work and how this informs his work

Key metrics used to track progress

Maximizing efficiency in a nonprofit organization

Other uses of data in the organization and the importance of demographics

JDRF’s involvement with advocacy and how they raise organizational awareness

Why Robert made the transition from the private to a nonprofit sector and how his goals drove his decision

Contact Robert Garelick at:

rgarelick@jdrf.org

Please post any questions or comments, thanks!

2017-11-04T18:05:00+00:00 By |Data Talks Podcast|0 Comments

About the Author:

Leave A Comment